Source: PIB
Context:
The Anusandhan National Research Foundation (ANRF), in partnership with the Indian Council of Medical Research (ICMR) and the Bill & Melinda Gates Foundation, has launched the Mission for Advancement in High-Impact Areas (MAHA) – Medical Technology (Maha MedTech). The initiative seeks to accelerate innovation, indigenization, and affordability in India’s medical technology sector while reducing dependence on costly imports.
Key Objectives of Maha MedTech Mission
- Public Health Impact: Support technologies that address priority diseases and improve access to safe and high-quality healthcare.
- Affordability and Accessibility: Encourage cost-effective and inclusive MedTech solutions to make healthcare more accessible to all.
- Self-Reliance and Competitiveness: Catalyze domestic innovation and manufacturing, strengthening India’s Atmanirbhar Bharat vision in the MedTech sector.
Funding Framework
- Eligible Entities: Academic and R&D institutions, hospitals, startups, MSMEs, and industry collaborations.
- Funding Range: ₹5–25 crore per project (up to ₹50 crore in exceptional cases).
- Disbursement Model: Milestone-linked funding, ensuring accountability and innovation outcomes.
Scope of the Mission
The mission encompasses a wide spectrum of medical devices and diagnostics, including:
- Equipment and subcomponents
- Implants, surgical and assistive devices
- Consumables and software-based solutions
- AI/ML-enabled platforms and robotics
Priority Areas: Tuberculosis, cancer, neonatal care, and primary healthcare — aligned with national health priorities and the Ayushman Bharat framework.
Enabling Ecosystem and Support Platforms
The Maha MedTech Mission will integrate several national initiatives to foster innovation and regulatory facilitation:
- Patent Mitra: Intellectual property protection and technology transfer assistance.
- MedTech Mitra: Support for regulatory guidance and market clearances.
- Clinical Trial Network: Facilitation of clinical validation and evidence generation.
- Mentorship: Guidance from industry experts and policymakers for commercialization readiness.
